JAN 04, 2017 06:30 PM PST

Scientists Unveil Unique Factors Contributing to Autoimmune Disease

WRITTEN BY: Kara Marker

Many autoimmune diseases come in waves, where symptoms temporarily get worse followed by a time of little to no signs of disease. There are a lot of factors that govern why and how an autoimmune disorder occurs, but a recent study was focused specifically on the quality of autoimmunity that causes flare-ups of disease. The same study ultimately resulted in the revealing of two key factors involved in this process, providing doctors and patients new hope for an autoimmune treatment.

Source: OnlineHealth.wiki

From the Schepens Eye Research Institute of Massachusetts Eye and Ear Infirmary, researchers focused on a mouse model of dry eye disease, an autoimmune disease that shares molecular similarities with multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and another chronic inflammatory eye disorder called uveitis. The common denominator is Th17 cells, which can continue living in the circulation for a relatively long time as memory cells.

They quickly identified interleukins (IL) 7 and 15, immune cytokines secreted by other immune cells that act as cell-signaling proteins. IL-7 and IL-15 play the role of memory regulation for Th17 cells, the researchers discovered. This enlightenment meant two new targets for treatments.

"By selectively targeting the production and expression of IL-7 and IL-15, we may be able to prevent the development of chronic autoimmune disorders,” explained senior author Reza Dana, MD, Msc, MPH. Dana’s study is the first to uncover how Th17 cells maintain memory.

During the study, when scientists neutralized IL-7 and IL-15, the result was a significant decrease in the number of memory Th17 cells, further highlighting the potential for the two interleukins as targets for a new autoimmune disease treatment.

"In the case of dry eye disease, many of the treatments are showing limited efficacy in patients that do not have a highly inflamed eye," Dana said. "Targeting the chronic, immune nature of autoimmune diseases may be a better strategy for controlling these conditions."

Dana’s study was recently published in the Journal of Autoimmunity.

Source: Massachusetts Eye and Ear Infirmary

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 08, 2018
Immunology
MAY 08, 2018
Nuclear Pore Complexes Vital for T Cell Survival
What’s happening on the molecular level that ensures protective T cells of the immune system will do their job? A new study from Sanford-Burnham Preb...
JUN 21, 2018
Immunology
JUN 21, 2018
The Silver Tsunami: An Aging Immune System and Cancer
Why do cases of cancer become more common as we get older? Scientists interested in explaining the so-called “Silver Tsunami” phenomenon look t...
JUN 25, 2018
Immunology
JUN 25, 2018
An Emerging Chronic Food Allergy: Eosinophilic Esophagitis
There’s a new food allergy in town, and it seems that children with existing allergies at an increased risk of developing it. From the Children&rsquo...
JUN 27, 2018
Immunology
JUN 27, 2018
Immune Cells Responsible for Chemo-induced Diarrhea
While studying specific immune cells in the context of chronic itching in the skin, two Washington University School of Medicine scientists discovered that...
JUL 15, 2018
Immunology
JUL 15, 2018
Enzyme Pathway Mediates Immune Response to Chagas Disease
The enzyme, PI3Kγ, regulates the immune response to T. cruzi, the cause of Chagas Disease. Manipulation of this enzyme may lead to better treatment of T. cruzi....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
Loading Comments...